Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.
Press releases published on August 8, 2025
DR. ROSALINE AMANGBO RECENTLY SELECTED AS TOP COMMERCIAL PROPERTY BROKER OF THE YEAR BY IAOTP
EIN Presswire
·
August 8, 2025
Dr. Rosaline Amangbo will be honored at the International Association of Top Professionals (IAOTP) annual awards gala in Las Vegas NEW YORK, NY, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- Dr. Rosaline Amangbo was recently selected as Top …
New bill to ban gender-affirming care raises concerns for both trans youth and FGM survivors, experts warn
EIN Presswire
·
August 8, 2025
Lawmakers urged to oppose bill H.R. 3492, which conflates female genital mutilation with gender-affirming care, putting FGM survivors and trans youth at risk. NEW YORK, NY, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- Leading legal, human rights, …
Weber Legal Nurse Consulting CEO to Address the Attorney’s Resource Conference in Detroit
EIN Presswire
·
August 8, 2025
Silvia Aninye will draw on her experience as an RN and Legal Nurse Consultant when she speaks about defense medical exams at Detroit conference, August 12th. DETROIT, MI, UNITED STATES, August 8, 2025 /EINPresswire.com/ -- Silvia Aninye, the CEO of …
XORTX Completes USD $114,500 Private Placement
GlobeNewswire
·
August 8, 2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 08, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late- …
Verde Announces Q2 2025 Earnings Results
GlobeNewswire
·
August 8, 2025
SINGAPORE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Verde AgriTech Ltd (TSX: “NPK”) ("Verde” or the “Company”) announces its financial results for the period ended June 30, 2025 (“Q2 2025”). All figures are in Canadian dollars, unless stated otherwise. Average …
Financial Results for the Second Quarter of 2025
GlobeNewswire
·
August 8, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the three and six months ended …
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 8, 2025
CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
GlobeNewswire
·
August 8, 2025
– Filing based on pivotal Phase 3 VERITAC-2 clinical trial demonstrating statistically significant and clinically meaningful improvement in median progression-free survival versus fulvestrant – – Vepdegestrant is the first PROteolysis TArgeting Chimera ( …
U.S. Imposes Additional 25% Tariff on Indian Goods Amid Rising Trade Pressures
EIN Presswire
·
August 8, 2025
As the Reserve Bank of India holds its benchmark rate at 5.5%, EBC Financial Group warns India’s external outlook may face greater pressure in the months ahead. INDIA, August 8, 2025 /EINPresswire.com/ -- U.S. President Donald Trump announced on August …
BLM Releases Draft EIS for the Grassy Mountain Gold Project
GlobeNewswire
·
August 8, 2025
WINNEMUCCA, Nev., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Paramount Gold Nevada Corp. (NYSE American: PZG) (“Paramount” or the “Company”) is pleased to announce that the U.S. Bureau of Land Management (“BLM”) has released its draft Environmental Impact Statement …
Terra Balcanica Lists on OTCQB Marketplace
GlobeNewswire
·
August 8, 2025
Vancouver, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA:UB10) is pleased to announce that its common shares have begun trading on the OTCQB marketplace under the symbol “TEBAF …
Tenaya Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference
GlobeNewswire
·
August 8, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
Vaxart CEO Issues Letter to Stockholders
GlobeNewswire
·
August 8, 2025
- Management Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on September 4, 2025 - SOUTH SAN FRANCISCO, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical- …
MAX Power Closes Financings for $4.45 Million with Eric Sprott as Lead Order
GlobeNewswire
·
August 8, 2025
VANCOUVER, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) (“MAX Power” or the “Company”) is pleased to announce that in conjunction with the previously announced closings of its non- …
Spectral Medical Announces Second Quarter and Provides Corporate Update
GlobeNewswire
·
August 8, 2025
Topline Tigris results expected to be released around mid-August 2025 TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and …
First American Uranium Announces Shares for Debt
GlobeNewswire
·
August 8, 2025
Vancouver, British Columbia, Aug. 08, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces that, it will enter into a debt settlement agreement for the issuance of 2,000,000 common shares in …
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
GlobeNewswire
·
August 8, 2025
FDA-approved protocol update significantly expands patient eligibility criteria for the BACKBEAT global pivotal study (“BACKBEAT study”), resulting in an estimated more than 24-fold increase in the potentially eligible patient pool as compared to original …
Y-mAbs Reports Second Quarter 2025 Financial Results and Recent Corporate Developments
GlobeNewswire
·
August 8, 2025
Reported Total Revenues of $19.5 million for the second quarter of 2025, exceeding the high end of the Company’s guidance range of between $17 million and $19 million SERB Pharmaceuticals to acquire Y-mAbs in $412.0 million transaction; transaction …
Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025
GlobeNewswire
·
August 8, 2025
Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the second quarter and first half ended 30 June 2025. The full report …